Literature DB >> 18190253

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.

Michel Ledizet1, Kalipada Kar, Harald G Foellmer, Nathalie Bonafé, Karen G Anthony, L Hannah Gould, Sandra L Bushmich, Erol Fikrig, Raymond A Koski.   

Abstract

The flavivirus envelope (E) protein mediates cellular attachment and fusion with host cell membranes and is recognized by virus-neutralizing antibodies. We raised antibodies against a broad range of epitopes by immunizing a horse with recombinant West Nile virus (WNV) E protein. To define epitopes recognized by protective antibodies, we selected, by affinity chromatography, immunoglobulins against immobilized linear peptides derived from parts of the E protein. Immunoglobulins binding 9 different peptides from domains I, II, and III of the E protein neutralized WNV in vitro. This indicates that multiple protective epitopes can be found in the E protein. Immunoglobulins recognizing 3 peptides derived from domains I and II of E protein protected mice against a lethal challenge with WNV. These immunoglobulins recognized the E proteins of related flaviviruses, demonstrating that antibodies targeting specific E protein epitopes could be developed for prevention and treatment of multiple flavivirus infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18190253     DOI: 10.1086/523654

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Closing the door on flaviviruses: entry as a target for antiviral drug design.

Authors:  Rushika Perera; Mansoora Khaliq; Richard J Kuhn
Journal:  Antiviral Res       Date:  2008-06-11       Impact factor: 5.970

2.  TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

Authors:  Stacey L Demento; Nathalie Bonafé; Weiguo Cui; Susan M Kaech; Michael J Caplan; Erol Fikrig; Michel Ledizet; Tarek M Fahmy
Journal:  J Immunol       Date:  2010-07-26       Impact factor: 5.422

3.  A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

Authors:  Nathalie Bonafé; Joseph A Rininger; Richard G Chubet; Harald G Foellmer; Stacey Fader; John F Anderson; Sandra L Bushmich; Karen Anthony; Michel Ledizet; Erol Fikrig; Raymond A Koski; Paul Kaplan
Journal:  Vaccine       Date:  2008-11-07       Impact factor: 3.641

4.  PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype.

Authors:  Petr Danecek; Wenzhe Lu; Catherine H Schein
Journal:  J Mol Biol       Date:  2009-12-04       Impact factor: 5.469

5.  Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.

Authors:  Hameeda Sultana; Harald G Foellmer; Girish Neelakanta; Theodore Oliphant; Michael Engle; Michel Ledizet; Manoj N Krishnan; Nathalie Bonafé; Karen G Anthony; Wayne A Marasco; Paul Kaplan; Ruth R Montgomery; Michael S Diamond; Raymond A Koski; Erol Fikrig
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

Review 6.  A review of vaccine approaches for West Nile virus.

Authors:  Arun V Iyer; Konstantin G Kousoulas
Journal:  Int J Environ Res Public Health       Date:  2013-09-10       Impact factor: 3.390

7.  Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe.

Authors:  Stefan Chabierski; Gustavo R Makert; Alexandra Kerzhner; Luisa Barzon; Petra Fiebig; Uwe G Liebert; Anna Papa; Justin M Richner; Matthias Niedrig; Michael S Diamond; Giorgio Palù; Sebastian Ulbert
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

8.  Constancy and diversity in the flavivirus fusion peptide.

Authors:  Stephen J Seligman
Journal:  Virol J       Date:  2008-02-14       Impact factor: 4.099

9.  Passive immunization against highly pathogenic Avian Influenza Virus (AIV) strain H7N3 with antiserum generated from viral polypeptides protect poultry birds from lethal viral infection.

Authors:  Mirza Imran Shahzad; Khalid Naeem; Muhammad Mukhtar; Azra Khanum
Journal:  Virol J       Date:  2008-11-28       Impact factor: 4.099

10.  An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.

Authors:  Dhiraj Acharya; Fengwei Bai
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.